In order to access this content you must be logged in and have a subscription to PL Intelligence.
PL Intelligence is a one-stop environment for time-conscious executives. Keeping you abreast of the latest developments in the life sciences industry, saving you time and money when you need it most.
Epimmune grants Anosys license to cancer epitopes
Epimmune and Merck Enter Into Agreement
Epimmune and Immuno-Designed Molecules agree license option
Immuno-Designed Molecules exercises license option
Epimmune and Aventis enter into license option agreement
Pharmexa acquires HPV patent portfolio from Seed Capital Investments BV
Epimmune receives Notice of Allowance for patent of core vaccine technology
Epimmune and Beckman Coulter sign license agreement
© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd 
All rights reserved. Terms and Conditions | Contact us
